Showing 3,641 - 3,660 results of 60,744 for search '(( 5 ((we decrease) OR (teer decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.30s Refine Results
  1. 3641

    Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

    Published 2022
    “…This study investigated the association between CLEC16A variants and AR risk in the Chinese population.</p><p>Methods: We applied Agena MassARRAY technology platform to genotype five single nucleotide polymorphisms (SNPs) located in CLEC16A in 1004 controls and 995 cases. …”
  2. 3642
  3. 3643

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  4. 3644

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  5. 3645

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  6. 3646

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  7. 3647

    C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

    Published 2021
    “…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”
  8. 3648
  9. 3649
  10. 3650

    ANOVA for DH (Y<sub>1</sub>) and IC<sub>50</sub> of LI (Y<sub>2</sub>). by Kittisak Kuptawach (18599047)

    Published 2024
    “…The peptide was synthesized and demonstrated LI with an IC<sub>50</sub> of 0.255 mM through a non-competitive mechanism, with a constant (K<sub>i</sub>) of 0.61 mM. …”
  11. 3651

    Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study by Shengnan Chen (3595319)

    Published 2022
    “…We found that DKD patients have a higher risk to develop 50% eGFR decline endpoint (HR:2.30, 95%CI [1.48–3.58], <i>p</i> < 0.001) and KRT endpoint (HR:1.64, 95%CI [1.13–2.37], <i>p</i> < 0.05) than NDKD patients. …”
  12. 3652
  13. 3653

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    “…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g<sup>–1</sup>; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g<sup>–1</sup> under the same conditions. …”
  14. 3654

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    “…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g<sup>–1</sup>; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g<sup>–1</sup> under the same conditions. …”
  15. 3655
  16. 3656
  17. 3657
  18. 3658
  19. 3659
  20. 3660